EXPD
37
-5
A
43
-3
STI
11
-2
FMC
16
-13
NFLX
37
2
XYL
41
-8
NTRS
64
-3
ADI
76
-4
EQIX
50
-3
NEE
52
-2
ABT
41
3
ROK
60
-6
BBY
45
-4
WYNN
34
-3
CCI
42
-2
MTCH
57
-2
SEE
56
3
CFG
93
-2
CMI
72
-5
SYF
83
-7
EXPD
37
-5
A
43
-3
STI
11
-2
FMC
16
-13
NFLX
37
2
XYL
41
-8
NTRS
64
-3
ADI
76
-4
EQIX
50
-3
NEE
52
-2
ABT
41
3
ROK
60
-6
BBY
45
-4
WYNN
34
-3
CCI
42
-2
MTCH
57
-2
SEE
56
3
CFG
93
-2
CMI
72
-5
SYF
83
-7
Financhill
Back

Consolidated Edison, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
39

ED
Consolidated Edison, Inc.

Last Price:
$97.50
Seasonality Move:
3.29%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
39
Consolidated Edison, Inc. (ED) is a Sell

Is Consolidated Edison, Inc. a Buy, Sell or Hold?

  • The current Consolidated Edison, Inc. [ED] share price is $97.53. The Score for ED is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ED is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ED Stock Price Chart

What is Consolidated Edison, Inc.'s stock price today?

  • The Consolidated Edison, Inc. share price today is $97.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ED is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

ED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.98 Sell
Relative Strength Index (14 RSI): 47.82 Sell
Chaikin Money Flow: 1665704 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (96.45 - 101.11) Sell
Bollinger Bands (100): (97.15 - 102.23) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

ED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.14 Buy
20-day SMA: 98.6 Sell
50-day SMA: 99.28 Sell
200-day SMA: 102.34 Sell
8-day EMA: 96.6 Buy
20-day EMA: 97.67 Sell
50-day EMA: 98.7 Sell
200-day EMA: 100 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Consolidated Edison, Inc. Earnings Growth & ED Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.37 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Consolidated Edison, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):